InvestorsHub Logo
Followers 0
Posts 1156
Boards Moderated 0
Alias Born 01/18/2013

Re: Jeff20134 post# 99

Friday, 05/09/2014 12:26:24 PM

Friday, May 09, 2014 12:26:24 PM

Post# of 290
Oh come on. I'm a long and don't have any such delusions. $5 is the high end for this company/product IMO if everything goes right.

For a $300 share price, you're talking about Stellar's researchers coming up with a cure for something big on their own. Outlandish claims/statements won't change panic selling.

Stellar has gotten the crap beaten out of it based upon the sell off in the biotech sector combined with the fact that they haven't had any substantial news in quite a while. This is a small company and without regular material news (and I don't consider an updated website or an IR firm to be "material news"), the share price gets beat up. This sell off is now getting way overdone. I have no idea how low it can go, but I suspect that things will start to turn around again after they report on the updates of the C.Diff. active immunotherapy program.

They have $15 million in cash and equivalents on the balance sheet. I don't think their position is as bad as some claim.

Insiders have not been selling.

http://www.canadianinsider.com/node/7?menu_tickersearch=Stellar+Biotechnologies%2C+Inc.+%7C+KLH

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.